Tech Company Financing Transactions
SetPoint Medical Funding Round
SetPoint Medical secured a $27 million funding round on 8/8/2013. Backers included Boston Scientific Corporation, Covidien Ventures and Flare Capital Partners.
Transaction Overview
Company Name
Announced On
8/8/2013
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Undisclosed
Investors
Flare Capital Partners (Andrew Firlik)
Morgenthaler Ventures (James Broderick)
Proceeds Purpose
The proceeds of the financing will be used to expand ongoing clinical development of the SetPoint bioelectronics therapy approach in rheumatoid arthritis and Crohn's disease and advance development of the SetPoint proprietary neuromodulation platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25101 Rye Canyon Loop
Valencia, CA 91355
USA
Valencia, CA 91355
USA
Phone
Website
Email Address
Overview
SetPoint Medical is a biomedical technology company developing neuromodulation therapies for patients with inflammatory autoimmune diseases, such as rheumatoid arthritis and Crohn's Disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Murthy Simhambhatla
Chief Medical Officer
David Chernoff
VP - Marketing
Ankit Shah
VP - Operations
John Long
VP - Product Management
William Calle
VP - R & D
Yaakov Levine
VP - Regulatory Affairs
Lusin Markaryan
Browse more venture capital transactions:
Prev: 8/8/2013: Trada venture capital transaction
Next: 8/8/2013: Innography venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs